Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure
Results from Cancer-Unaffected BRCA1/2 Mutation Carriers
Bibliographic Data
Women who are found to carry a BRCA1/2 pathogenic variant experience psychological distress due to an increased risk of breast and ovarian cancer. They may decide between different preventive options. In this secondary analysis of data collected alongside a larger randomized controlled trial, we are looking at 130 newly found BRCA1/2 pathogenic variant carriers and how their coping self-efficacy immediately after genetic test result disclosure is related to their psychological burden and status of preventive decision making. Participants received the Coping Self-Efficacy Scale, the Hospital Anxiety and Depression Scale, the Impact of Event Scale, the Decisional Conflict Scale, and the Stage of Decision-Making Scale after positive genetic test result disclosure. We found that women with higher coping self-efficacy showed fewer symptoms of anxiety or depression and were less affected by receiving the genetic test result in terms of post-traumatic stress. However, coping self-efficacy had no relationship with any decision-related criteria, such as decisional conflict or stage of decision making. This shows that despite its buffering capacity on psychological burden, possessing coping self-efficacy does not lead to more decisiveness in preference-sensitive decisions
Anxiety · Avoidance coping · Breast cancer · Cancer · Coping (psychology · Distress · Psychiatry · BRCA gene mutations in cancer · Clinical Psychology · Ethics in Clinical Research · Health Systems, Economic Evaluations, Quality of Life · Medicine · Psychology · Internal Medicine
| Citation velocity | historical |
|---|---|
| Highly cited | No |